Skip to main content
Article thumbnail
Location of Repository

C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria

By Andrea Conroy, Lena Serghides, Constance Finney, Simon O. Owino, Sanjeev Kumar, D. Channe Gowda, W. Conrad Liles, Julie M. Moore and Kevin C. Kain
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2655724
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1996). Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.
    2. (1983). An analysis of malaria in pregnancy in Africa.
    3. (2006). An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    4. (2003). At the innate frontiers between mother and fetus: linking abortion with complement activation.
    5. (2005). Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype.
    6. (2008). C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.
    7. (2004). CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages.
    8. (2003). Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria.
    9. (1996). Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy.
    10. (2004). Circulating angiogenic factors and the risk of preeclampsia.
    11. (2005). Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.
    12. (2007). Complement activation in experimental human malaria infection. Trans R Soc Trop Med Hyg
    13. (1997). Complement activation in severe Plasmodium falciparum malaria.
    14. (2006). Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
    15. (2004). Complement-induced impairment of the innate immune system during sepsis.
    16. (1989). Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells.
    17. (2002). Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women.
    18. (1978). Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
    19. (1989). Endotoxin-induced shock in the rat. A role for C5a.
    20. (2007). Evolving functions of endothelial cells in inflammation.
    21. (2007). Function, structure and therapeutic potential of complement C5a receptors.
    22. (2008). Functional roles for C5a receptors in sepsis.
    23. (2002). Generation of C5a by phagocytic cells.
    24. (2006). Generation of C5a in the absence of C3: a new complement activation pathway.
    25. (2007). Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection.
    26. (2000). Glycosylphosphatidylinositol Anchors of Plasmodium falciparum: Molecular Characterization and Naturally Elicited Antibody Response That May Provide Immunity to Malaria Pathogenesis.
    27. (2003). Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression.
    28. (1999). Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria.
    29. (2005). Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas.
    30. (2008). Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum.
    31. (2002). Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria.
    32. (1997). Incidence of clinical malaria in pregnant women exposed to intense perennial transmission.
    33. (2005). Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity.
    34. (2003). Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection.
    35. (2007). LPS induces secretion of chemokines by human syncytiotrophoblast cells in a MAPK-dependent manner.
    36. (1999). Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation.
    37. (1998). Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes.
    38. (1969). Malaria, anaemia and pregnancy.
    39. (1996). Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol Res Pract 192: 892–898; discussion 899–900.
    40. (1998). Massive chronic intervillositis of the placenta associated with malaria infection.
    41. (2008). Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria.
    42. (2008). Natural selection of FLT1 alleles and their association with malaria resistance in utero.
    43. (1981). Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    44. (2000). Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparumparasitized erythrocytes: a role for CD36 in malarial clearance.
    45. (2006). Placental chondroitin sulfate Abinding malarial isolates evade innate phagocytic clearance.
    46. (2003). Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes.
    47. (2003). Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women.
    48. (2000). Placental vascular morphogenesis.
    49. (1989). Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study.
    50. (1999). Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection.
    51. (2006). Plasmodium falciparum-infected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast.
    52. (1999). Protective effects of C5a blockade in sepsis.
    53. (2004). Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    54. (2005). Role of C5a in inflammatory responses.
    55. (2001). Role of C5a in multiorgan failure during sepsis.
    56. (2007). Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.
    57. (2005). Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors.
    58. (2004). The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.
    59. (2006). The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
    60. (2004). The dark side of C5a in sepsis.
    61. (2003). The enigma of sepsis.
    62. (2000). The impact of placental malaria on gestational age and birth weight.
    63. (2003). The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.
    64. (2002). Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.